AU2021286295A1 — Therapeutic Inhibition of Lactate Dehydrogenase and Agents Therefor
Assigned to Novo Nordisk Health Care AG · Expires 2022-01-06 · 4y expired
What this patent protects
FIG. I Ane2 cleavage sites 1 Ri 5' -CAALJUUUAAGUCUUCUGAUGUCAU-3' SEQIDNO:252 DsiRNA25/27mer 3'-ACGUUAAAAUIUCAGAAGACUACAGUA-5' SEQIDNO:108 siRNA21mer 5' -CAAUUUUAA AGUCUUCUGAUG-3'1 SEQ ID NO: 7123 3'ACGUUAAAAUUJhACAAGACU-5' SEQIDNO:7124 DsiRNA 27/27 5'-UGCAAUUUUAAAGUCUUCUGAU…
USPTO Abstract
FIG. I Ane2 cleavage sites 1 Ri 5' -CAALJUUUAAGUCUUCUGAUGUCAU-3' SEQIDNO:252 DsiRNA25/27mer 3'-ACGUUAAAAUIUCAGAAGACUACAGUA-5' SEQIDNO:108 siRNA21mer 5' -CAAUUUUAA AGUCUUCUGAUG-3'1 SEQ ID NO: 7123 3'ACGUUAAAAUUJhACAAGACU-5' SEQIDNO:7124 DsiRNA 27/27 5'-UGCAAUUUUAAAGUCUUCUGAUGUCAU-3' SEQ ID NO: 396 BImt/Blunt 3' -ACGUUAAAAUUUCAGAAACqCAGUA-5' SEQ 10 NO: 108 siRNAC2mer 5'-UCAAUUUUAt'GUCUUCUGA-3' SEQ ID NO: 324 Blunt-Bluit 3' -ACGUUAAAAUUCAGAAGACU-5' SEQ 10 NO: 7124 DsiRNA 27/27 5'-UGCAAUUUUAMGUCUUCUGAUGUCCC-3' SEQ ID NO: 7125 Blat/Fray-R 3' -ACGUUAAAAUU:UCAGAAGACLACAGUA-5' SEQ ID NO: 108 siRNA 21mer 5'-UGCAAUUUUAAAGUCUUCUAC-3' SEQ ID NO: 7126 BluntFray-R 3r-ACGUUAAAAUU;UCAGAAGACU-5' SEQ ID NO: 7124 This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of dsRNAs, e.g. Dicer substrate siRNA (DsiRNA) agents.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.